Metallothionein-protein interactions

Biomolecular Concepts

Volumn 4, Issue 2, 2013, Pages 143-160

  Atrian, Sílvia ^a   Capdevila, Mercè ^b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

CNS metal ions; Metal ions and cancer; Metallothionein; Neurodegenerative disorders; Protein protein interaction

Indexed keywords

BOVINAE; MAMMALIA;

METALLOTHIONEIN; PROTEIN AGGREGATE; PROTEIN BINDING; REACTIVE OXYGEN METABOLITE;

ANIMAL; BRAIN; CHEMISTRY; DEGENERATIVE DISEASE; GENE EXPRESSION REGULATION; HUMAN; KIDNEY; METABOLISM; NEOPLASM; PROTEIN CONFORMATION; SYNAPTIC TRANSMISSION;

ANIMALS; BRAIN; GENE EXPRESSION REGULATION; HUMANS; KIDNEY; METALLOTHIONEIN; NEOPLASMS; NEURODEGENERATIVE DISEASES; PROTEIN AGGREGATES; PROTEIN BINDING; PROTEIN CONFORMATION; REACTIVE OXYGEN SPECIES; SYNAPTIC TRANSMISSION;

EID: 84876577823     PISSN: 18685021     EISSN: 1868503X     Source Type: Journal    
DOI: 10.1515/bmc-2012-0049     Document Type: Review

References (100)

1. Margoshes M, Vallee B. A cadmium protein from equine kidney cortex. Am Chem Soc 1957; 79: 4813-4.
2. Sigel A, Sigel H, Sigel RKO, editors. Metallothioneins and related chelators. Metal ions in life sciences, vol. 5. Cambridge, UK: RSC Publishing, 2009.
3. Palacios O, Atrian S, Capdevila M. Zn- and Cu-thioneins: a functional classification for metallothioneins ? J Biol Inorg Chem 2012; 17: 991-1009.
4. Capdevila M, Bofill R, Palacios O, Atrian S. State-of-the-art of metallothioneins at the beginning of the 21st century. Coord Chem Rev 2011; 256: 46-62.
5. Blindauer C, Leszczyszyn OI. Metallothioneins: unparalleled diversity in structures and functions for metal ion homeostasis and more. Nat Prod Rep 2010; 27: 720-41.
6. Dolderer B, Hartmann HJ, Weser S. Metallothioneins in yeasts and fungi. In: Sigel A, Sigel H, Sigel RKO, editors. Metallothioneins and related chelators. Metal ions in life sciences, vol. 5. Cambridge, UK: RSC Publishing, 2009: 83-106.
7. Calderone V, Dolderer B, Hartmann HJ, Echner H, Luchinat C, Del Bianco C, Mangani S, Weser U. The crystal structure of yeast copper thionein: the solution of a long-lasting enigma. Proc Natl Acad Sci USA 2005; 102: 51-6.
8. Atrian S. Metallothioneins in Diptera. In: Sigel A, Sigel H, Sigel RKO, editors. Metallothioneins and related chelators. Metal ions in life sciences, vol. 5. Cambridge, UK: RSC Publishing, 2009: 155-81.
9. Perez-Rafael S, Kurz A, Guirola M, Capdevila M, Palacios O, Atrian S. Is MtnE, the fifth Drosophila metallothionein, functionally distinct from the other members of this polymorphic protein family ? Metallomics 2012; 4: 342-9.
10. Moleirinho A, Carneiro J, Matthiesen R, Silva RM, Amorim A, Azevedo L. Gains, losses and changes of function after gene duplication: study of the metalothionein family. PLoS ONE 2011; 6: e18487.
11. Bofill R, Capdevila M, Atrian S. Independent metal-binding features of recombinant metallothioneins convergently draw a step gradation between Zn- and Cu-thioneins. Metallomics 2009; 1: 229-34.
12. Tío L, Villarreal L, Atrian S, Capdevila M. Functional differentiation in the mammalian metallothionein gene family: metal binding features of mouse MT4 and comparison with its paralog MT1. J Biol Chem 2004; 279: 24403-13.
13. Vasak M, Meloni G. Chemistry and biology of mammalian metallothioneins. J Biol Inorg Chem 2011; 16: 1067-78.
14. Kägi JHR, Vallee BL. Metallothionein: a cadmium- and zinc-containing protein from equine kidney cortex. J Biol Chem 1960; 235: 3460-5.
15. Sabolic I. Common mechanisms in nephropathy induced by toxic metals. Nephron Physiol 2006; 104: 107-14.
16. Klassen RB, Crenshaw K, Kozyraki R, Verroust PJ, Tio L, Atrian S, Allen PL, Hammond TG. Megalin mediates renal uptake of heavy metal metallothionein complexes. Am J Physiol Renal Physiol 2004; 287: F393 - 403.
17. Onodera A, Tani M, Michigami T, Yamagata M, Min K-S, Tanaka K, Nakanishi T, Kimura T, Itoh N. Role of megalin and the soluble form of its ligand RAP in Cd-metallothionein endocytosis and Cd-metallothionein-induced nephrotoxicity in vivo. Toxicol Lett 2012; 212: 91-6.
18. Santos CR, Martinho A, Quintela T, Gonçalves I. Neuroprotective and neuroregenerative properties of metallothioneins. IUBMB Life 2012; 64: 126-35.
19. Good M, Vasak M. Iron(II)-substituted metallothionein: evidence for the existence of iron-thiolate clusters. Biochemistry 1986; 25: 8353-6.
20. Ribas B, Pelayo JF. Isolation of brain metallothionein labelled with 59 iron in anemic rats. Toxicol Environ Chem 1989; 23: 9-15.
21. Uchida Y, Takio K, Titani K, Ihara Y, Tomogana M. The growth inhibitory factor that is deficient in Alzheimer ' s disease brain is a 68 amino acid metallothionein-like protein. Neuron 1991; 7: 337-47.
22. Duguid JR, Bohmont CW, Liu N, Tourtellotte WW. Changes in brain gene expression shared by scrapie and Alzheimer ' s disease. Proc Natl Acad Sci USA 1989; 86: 7260-4.
23. Adlard PA, West AK, Vickers JC. Increased density of metallothionein I/II-immunopositive cortical glial cells in the early stages of Alzheimer ' s disease. Neurobiol Dis 1998; 5: 349-56.
24. Zambenedetti P, Giordano R, Zatta P. Metallothioneins are highly expressed in astrocytes and microcapillaries in Alzheimer ' s disease. J Chem Neuroanat 1998; 15: 21-6.
25. Carrasco J, Adlard PA, Cotman C, Quintana A, Penkowa M, Xu F, Van Nostrand WE, Hidalgo J. Metallothionein-I and -III expression in animal models of Alzheimer disease. Neuroscience 2006; 143: 911-22.
26. Tsuji S, Kobayashi H, Uchida Y, Ihara Y, Miyatake T. Molecular cloning of human growth inhibitory factor cDNA and its down-regulation in Alzheimer ' s disease. EMBO J 1992; 11: 4843-50.
27. Yu WH, Lukiw WJ, Bergeron C, Niznik HB, Fraser PE. Metallothionein III is reduced in Alzheimer ' s disease. Brain Res 2001; 894: 37-45.
28. Erickson JC, Sewell AK, Jensen LT, Winge DR, Palmiter RD. Enhancer neurotrophic activity in Alzheimer ' s disease cortex is not associated with down-regulation of metallothionein-III (GIF). Brain Res 1994; 649: 297-304.
29. Mocchegiani E, Giacconi R, Cipriano C, Muzzioli M, Fattoretti P, Bertoni-Freddari C, Isani G, Zambenedetti P, Zatta P. Zinc-bound metallothioneins as potential biological markers of ageing. Brain Res Bull 2001; 55: 147-53.
30. Carrasco J, Giralt M, Molinero A, Penkowa M, Moos T, Hidalgo J. Metallothionein (MT)-III: generation of polyclonal antibodies, comparison with MT-I + II in the freeze lesioned rat brain and in a bioassay with astrocytes, and analysis of Alzheimer ' s disease brains. J Neurotrauma 2009; 16: 1115-29.
31. Mirza B, Hadberg H, Thomsen P, Moos T. The absence of reactive astrocytosis is indicative of a unique inflammatory process in Parkinson ' s disease. Neuroscience 2000; 95: 425-32.
32. Uchida Y. Growth-inhibitory factor, metallothionein-like protein, and neurodegenerative diseases. Biol Signals 1994; 3: 211-5.
33. Duguid JR, Rohwer RG, Seed B. Isolation of cDNAs of scrapiemodulated RNAs by substractive hybridization of a cDNA library. Proc Natl Acad Sci USA 1988; 85: 5738-42.
34. Kawashima T, Doh-ura K, Torisu M, Uchida Y, Furuta A, Iwaki T. Differential expression of metallothioneins in human prion disease. Dement Geriatr Cogn Disord 2000; 11: 251-62.
35. Sillevis-Smitt PA, Mulder TP, Verspaget HW, Blaauwgeers HG, Troost D, de Jong JM. Metallothioneins in amyotrophic lateral sclerosis. Biol Signals 1994; 3: 193-7.
36. Penkowa M, Espejo C, Ortega-Aznar A, Hidalgo J, Montalban X, Martínez-Caceres EM. Metallothionein expression in the central nervous system of multiple sclerosis patients. Cell Mol Life Sci 2003; 60: 1258-66.
37. Hidalgo J. Metallothioneins and brain injury: what transgenic mice tell us. Health Prev Med 2004; 9: 87-94.
38. Fitzgerald M, Nairn P, Bartlett CA, Chung RS, West AK, Beazley LD. Metallothionein-IIa promotes neurite growth via the megalin receptor. Exp Brain Res 2007; 183: 171-80.
39. Ambjørn M, Asmussen JW, Lindstam M, Gotfryd K, Jacobsen C, Kiselyov VV, Moestrup SK, Penkowa M, Bock E, Berezin V. Metallothionein and a peptide modeled after metallothionein, EmtinB, induce neuronal differentiation and survival through binding to receptors of the low-density lipoprotein receptor family. J Neurochem 2008; 104: 21-37.
40. Schwarzman AL, Gregori L, Vitek MP, Lyubski S, Strittmatter WJ, Enghilde JJ, Bhasin R, Silverman J, Weisgraber KH, Coyle PK, Zagorski MG, Talafous J, Eisenberg M, Saunders AM, Roses AD, Goldgaber D. Transthyretin sequesters amyloid β protein and prevents amyloid formation. Proc Natl Acad Sci USA 1994; 91: 8368-72.
41. Gonçalves I, Quintela T, Baltazar G, Almeida MR, Saraiva MJ, Santos CR. Transthyretin interacts with metallothionein 2. Biochemistry 2008; 47: 2244-51.
42. Martinho A, Gonçalves I, Cardoso I, Almeida MR, Quintela T, Saraiva MJ, Santos CR. Human metallothioneins 2 and 3 differentially affect amyloid- β binding by transthyretin. FEBS J 2010; 277: 3427-36.
43. Kang QH, Chen QL, Ren HW, Ru BG. Growth inhibitory factor (GIF) directly interacts with G-protein Rab3a. Prog Biochem Biophys 2001; 28: 880-4.
44. Knipp M, Meloni G, Roschitzki B, Vasak M. Zn 7 -metallothionein-3 and the synaptic vesicle cycle: interaction of metallothionein-3 with the small GTPase Rab3A. Biochemistry 2005; 44: 3159-65.
45. Lahti DW, Hoekman JD, Tokheim AM, Martin BL, Armitage IM. Identification of mouse brain proteins associated with isoform 3 of metallothionein. Protein Sci 2005; 14: 1151-7.
46. El Ghazi I, Martin BL, Armitage IM. Metallothionein-3 is a component of a multiprotein complex in the mouse brain. Exp Biol Med 2006; 231: 1500-6.
47. El Ghazi I, Martin BL, Armitage IM. New proteins found interacting with brain metallothionein-3 are linked to secretion. Int J Alzheimers Dis. 2011; 2011: 208634.
48. Meloni G, Faller P, Vasak M. Redox silencing of copper in metal-linked neurodegenerative disorders: reaction of Zn 7 -metallothionein-3 with Cu 2 + ions. J Biol Chem 2007; 282: 16068-78.
49. Meloni G, Sonois V, Delaine T, Guilloreau L, Gillet A, Teissie J, Faller P, Vasak M. Metal swap between Zn 7 -metallothionein-3 and amyloid- β -Cu protects against amyloid- β toxicity. Nat Chem Biol 2008; 4: 366-72.
50. Durand J, Meloni G, Talmard C, Vasak M, Faller P. Zinc release of Zn 7 -metallothionein-3 induces fibrillar type amyloid- β aggregates. Metallomics 2010; 2: 741-4.
51. Deshpande A, Kawai H, Metherate R, Glabe CG, Busciglio J. A role for synaptic zinc in activity-dependent A β oligomer formation and accumulation at excitatory synapses. J Neurosci 2009; 29: 4004-15.
52. Pedersen JT, Teilum K, Hureau C, Hemmingsen L, Heegaard NH, Østergaard J, Vasak M, Faller P. Rapid exchange of metal between Zn 7 -metallothionein-3 and amyloid- β peptide promotes amyloid-related structural changes. Biochemistry 2012; 51: 1697-706.
53. Pedersen JT, Hureau C, Heegaard NH, Østergaard J, Adolph HW, Hemmingsen L. Rapid formation of a preoligomeric peptidemetal- peptide complex following copper (II) binding to amyloid β peptides. Angew Chem Int Ed 2011; 50: 2532-5.
54. Jacob C, Maret W, Vallee BL. Control of zinc transfer between thionein, metallothionein and zinc proteins. Proc Natl Acad Sci USA 1998; 95: 3489-94.
55. Kim J-H, Nam Y-P, Jeon S-M, Han H-S, Suk K. Amyloid neurotoxicity is attenuated by metallothionein: dual mechanisms at work. J Neurochem 2012; 121: 751-62.
56. Hua H, Münter L, Harmeier A, Georgiev O, Multhaup G, Schaffner W. Toxicity of Alzheimer ' s disease-associated a peptide is ameliorated in a Drosophila model by tight control of zinc and copper availability. Biol Chem 2011; 392: 919-26.
57. Binolfi A, Rodriguez EE, Valensin D, D ' Amelio N, Ippoliti E, Obal G, Duran R, Magistrato A, Pritsch O, Zweckstetter M, Valensin G, Carloni P, Quintanar L, Griesinger C, Fernández CO. Bioinorganic chemistry of Parkinson's disease: structural determinants for the copper-mediated amyloid formation of α -synuclein. Inorg Chem 2010; 49: 10668-79.
58. Meloni G, Vasak M. Redox activity of α -synuclein-Cu is silenced by Zn 7 -metallothionein-3. Free Radic Biol Med 2011; 50: 1471-9.
59. Sharma S, Ebadi M. Metallothioneins as early and sensitive biomarkers of redox signalling in neurodegenerative disorders. IIOABJ 2011; 2: 98-106.
60. Viles JH, Klewpatinond M, Nadal RC. Copper and the structural biology of the prion protein. Biochem Soc Trans 2008; 36: 1288-92.
61. Meloni G, Crameri A, Fritz G, Davies P, Brown DR, Kroneck PMH, Vasak M. The catalytic redox activity of prion protein-Cu II is controlled by metal exchange with the Zn II -thiolate clusters of Zn 7 -metallothionein 3. ChemBioChem 2012; 13: 1261-5.
62. Orihuela R, Fernández B, Palacios O, Valero E, Atrian S, Watt RK, Domínguez-Vera JM, Capdevila M. Ferritin and metallothionein: dangerous liaisons. Chem Commun 2011; 47: 12155-7.
63. Andreini C, Banci L, Bertini I, Rosato A. Counting the zinc-proteins encoded in the human genome. J Proteome Res 2006; 5: 196-201.
64. Bell SG, Vallee BL. The metallothionein/thionein system: an oxidoreductive metabolic link. ChemBioChem 2009; 10: 55-62.
65. Udom AO, Brady FO. Reactivation in vitro of zinc-requiring apo-enzymes by rat liver zinc-thionein. Biochem J 1980; 187: 329-35.
66. Jiang L-J, Maret W, Vallee BL. The glutathione redox couple modulates zinc transfer from metallothionein to zinc-depleted sorbitol dehydrogenase. Proc Natl Acad Sci USA 1998; 95: 3483-8.
67. Maret W, Jacob C, Vallee BL, Fisher EH. Inhibitory sites in enzymes: zinc removal and reactivation by thionein. Proc Natl Acad Sci USA 1999; 96: 1936-40.
68. Zeng J, Heuchel R, Schaffner W, Kägi JHR. Thionein (apometallothionein) can modulate DNA binding and transcription activation by zinc finger containing factor Sp1. FEBS Lett 1991; 279: 310-2.
69. Zeng J, Vallee BL, Kägi JHR. Zinc transfer from transcription factor IIIA fingers to thionein clusters. Proc Natl Acad Sci USA 1991; 88: 9984-8.
70. Huang M, Shaw III F, Petering DH. Interprotein metal exchange between transcription factor IIIa and apo-metallothionein. J Inorg Biochem 2004; 98: 639-48.
71. Westin G, Schaffner W. A zinc-responsive factor interacts with a metal-regulated enhancer element (MRE) of the mouse metallothionein-I gene. EMBO J 1988; 7: 3763-70.
72. Maret W. Zinc and sulfur: a critical biological partnership. Biochemistry 2004; 43: 3301-9.
73. Feng W, Cai J, Pierce WM, Franklin RB, Maret W, Benz FW, Kang YJ. Metallothionein transfers zinc to mitochondrial aconitase through a direct interaction in mouse hearts. Biochem Biophys Res Commun 2005; 332: 853-8.
74. Lynes MA, Zaffuto K, Unfricht DW, Marusov G, Samson JS, Yin X. The physiological roles of extracellular metallothionein. Exp Biol Med 2006; 231: 1548-54.
75. Andrews GK, Kage K, Palmiter-Thomas P, Sarras MP Jr. Metal ions induce expression of metallothionein in pancreatic exocrine and endocrine cells. Pancreas 1990; 5: 548-54.
76. Trayhurn P, Duncan JS, Wood AM, Beattie JH. Metallothionein gene expression and secretion in white adipose tissue. Am J Physiol 2000; 279: R2329 - 35.
77. Quiming NS, Vergel RB, Nicolas MG, Villanueva JA. Interaction of bovine serum albumin and metallothionein. J Health Sci 2005; 51: 8-15.
78. Cherian MG, Jayasurya A, Bay BH. Metallothioneins in human tumors and potential roles in carcinogenesis. Mutat Res 2003; 533: 201-9.
79. Theocharis SE, Margeli AP, Klijanienko JT, Kouraklis GP. Metallothionein expression in human neoplasia. Histopathology 2004; 45: 103-18.
80. Pedersen M Ø, Larsen A, Stoltenberg M, Penkowa M. The role of metallothionein in oncogenesis and cancer prognosis. Prog Histochem Cytochem 2009; 44: 29-64.
81. Eckschlager T, Adam V, Hrabeta J, Figova K, Kizek R. Metallothionein and cancer. Curr Protein Pept Sci 2009; 10: 360-75.
82. Shu K-Z, Li B, Xu L-X. The p53 network: p53 and its downstream genes. Colloids Surf B 2007; 55: 10-8.
83. Loh SN. The missing zinc: p53 misfolding and cancer. Metallomics 2010; 2: 442-9.
84. Meplan C, Richard M-J, Hainaut P. Metalloregulation of the tumor suppressor protein p53: zinc mediates the renaturation of p53 after exposure to metal chelators in vitro and in intact cells. Oncogene 2000; 19: 5227-36.
85. Ostrakhovitch EA, Olsson P-E, Jiang S, Cherian MG. Interaction of metallothionein with tumor suppressor p53 protein. FEBS Lett 2006; 580: 1235-8.
86. Abdel-Mageed AB, Agrawal KC. Activation of nuclear factor κ B: potential role in metallothionein-mediated mitogenic response. Cancer Res 1998; 58: 2335-8.
87. Rao PS, Jaggi M, Smith DJ, Hemstreet GP, Balaji KC. Metallothionein 2A interacts with the kinase domain of PKC μ in prostate cancer. Biochem Biophys Res Com 2003; 310: 1032-8.
88. Tio L, Pagani M-A, Atrian S. Drosophila proteins interacting with metallothioneins: a metal-dependent recognition. Proteomics 2009; 9: 2568-77.
89. Radyuk SN, Klichko VI, Spinola B, Sohal RS, Orr WC. The peroxiredoxin gene family in Drosophila melanogaster. Free Radic Biol Med 2001; 31: 1090-100.
90. Maret W. Metallothionein redox biology in the cytoprotective and cytotoxic functions of zinc. Exp Gerontol 2008; 43: 363-9.
91. Li Y, Hawkins BE, Prough DS, DeWitt DS, Maret W. The relationship between transient zinc ion fluctuations and redox signaling in the pathways of secondary cellular injury: relevance to traumatic brain injury. Brain Res 2010; 1330: 131-41.
92. Maret W. Redox biochemistry of mammalian metallothioneins. J Biol Inorg Chem 2011; 16: 1079-86.
93. Mao J, Yu H, Wang C, Sun L, Jiang W, Zhang P, Qianyi X, Saiyin H, Zhu J, Chen T, Roberts LR, Huang H, Yu L. Metallothionein MT1M is a tumor suppressor of human hepatocellular carcinomas. Carcinogenesis 2012; 33: 2568-77.
94. Hidalgo J, Chung R, Penkowa M, Vasak M. Structure and function of vertebrate Metallothioneins. In: Sigel A, Sigel H, Sigel RKO, editors. Metallothioneins and related chelators. Metal ions in life sciences, vol. 5. Cambridge, UK: RSC Publishing, 2009: 279-317.
95. Vasak M, Meloni G. Metallothionein-3, zinc, and copper in the central nervous system. In: Sigel A, Sigel H, Sigel RKO, editors. Metallothioneins and related chelators. Metal ions in life sciences, vol. 5. Cambridge, UK: RSC Publishing, 2009: 319-52.
96. Penkowa M, Giralt M, Camats J, Hidalgo J. Metallothionein 1 + 2 protect the CNS during neuroglial degeneration induced by 6-aminonicotinamide. J Comp Neurol 2002; 444: 174-89.
97. Aschner M, Cherian MG, Klaassen CD, Palmiter RD, Erickson JC, Bush AI. Metallothioneins in brain - the role in physiology and pathology. Toxicol Appl Pharmacol 1997; 142: 229-42.
98. Morellini NM, Giles NL, Rea S, Adcroft KF, Falder S, King CE, Dunlop SA, Beazley LD, West AK, Wood FM, Fear MW. Exogenous metallothionein-IIA promotes accelerated healing after a burn wound. Wound Repair Regen 2008; 16: 682-90.
99. Morellini NM, Fear MW, Rea S, West AK, Wood FM, Dunlop SA. Burn injury has a systemic effect on reinnervation of skin and restoration of nociceptive function. Wound Repair Regen 2012; 20: 367-77.
100. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE. UCSF Chimera - a visualization system for exploratory research and analysis. J Comput Chem 2004; 25: 1605-12.